Pre- and post- transplantation lung cancer in heart transplant recipients.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 25952208.
- Also identified by DOI 10.1016/j.athoracsur.2014.07.081.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Heart transplantation after lung cancer surgery can be questionable because of the high risk of cancer recurrence. We report the results of two patients. The first underwent right lobectomy in 2008 for pT1N0 adenocarcinoma, heart-transplantation in 2010, and surgery for synchronous adenocarcinoma and squamous-cell carcinoma in 2012. The second underwent left segmentectomy for pT1aN0 adenosquamous carcinoma and transplantation in 1995 and then surgery for pT1aN1 adenocarcinoma in 2013. Posttransplantation lung cancer histologic analysis results were different in both cases, demonstrating the absence of metastatic recurrence. Thus, early stage lung cancer might not be a contraindication to heart transplantation, nor are long delays be necessary before registering on a waiting list.
Medical subject headings
- Adenocarcinoma
- Carcinoma, Adenosquamous
- Carcinoma, Squamous Cell
- Heart Failure
- Heart Transplantation
- Lung Neoplasms
- Neoplasms, Multiple Primary
- Pneumonectomy